• FirefoxInstall the new Firefox »
  •  Dow Down 0.23% Nasdaq Down 0.27%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    25.96 Down 0.24(0.92%) Mar 26, 4:00PM EDT
    Add to Portfolio
    Prev Close:26.20
    Open:25.85
    Bid:24.33 x 300
    Ask:28.30 x 500
    1y Target Est:37.44
    Beta:2.62
    Earnings Date:Apr 29 - May 4 (Est.)
    Day's Range:25.12 - 26.56
    52wk Range:10.76 - 32.82
    Volume:2,336,520
    Avg Vol (3m):2,356,580
    Market Cap:2.33B
    P/E (ttm):N/A
    EPS (ttm):-1.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLDX

    Comparison

    Symbol% ChgMkt Cap
    CLDXDown 0.92%2.33B
    DNDN 0.00%N/A
    LLYDown 1.24%77.89B
    RHHBYDown 1.61%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):654.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.52
    Quarterly EPS Est (Mar-15) :-0.36
    Mean Recommendation*:1.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback